AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC)

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
355
AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) Symposium Highlights the Application of Biophysical Technology in Cancer Prevention and Treatment

- AnPac Bio-Medical Science Co., Ltd. held its 2021 technical symposium, entitled “The Applications of Biophysical Technology in Cancer Prevention and Treatment” in Shanghai, China, on August 6, 2021
- The symposium included attendees from various hospitals, universities, and Fortune 500 companies, including Thermo Fisher Scientific and AnPac Bio’s contract partner Roche Pharmaceuticals China
- A recent report from Frost & Sullivan ranked AnPac Bio at #3 in the world and 1st in China for the number of clinical samples analyzed amongst companies that offer next-generation early cancer screening and detection technology

AnPac Bio-Medical Science (NASDAQ: ANPC) recently held its 2021 technical symposium entitled “The Applications of Biophysical Technology in Cancer Prevention and Treatment.” The symposium was held in Shanghai, China, and was attended by life science Fortune 500 companies such as Thermo Fisher Scientific and Roche Pharmaceuticals.

Experts came together to discuss emerging cancer prevention and treatment theories and technologies, including the applications of biophysical technology to address these needs. Measurement of biophysical properties is the basis for Anpac Bio’s novel CDA technology. The Company’s CDA technology can rapidly detect 26 different types of cancers with a simple blood test.

Talking points of the symposium included the newly announced cooperation between AnPac Bio and Roche Pharmaceutical China, as well as Thermo Fisher Scientific’s latest developments in in-vitro diagnosis (“IVD”), and the clinical trials that have been held on AnPac Bio’s proprietary cancer differentiation analysis (“CDA”) technology, including recently unblinded and analyzed clinical data.

AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter, and multi-cancer screening. The innovative technology has opened up a new field in early cancer screening that is based on a biophysical properties and has achieved significant results. In 2019, Frost & Sullivan ranked AnPac Bio third in the world and first in China among those companies in the region in terms of the number of clinical samples offering next-generation early cancer screening and detection.

With one of the largest sample libraries in the world and more than 220,000 samples tested, AnPac Bio is an innovative leader in the field. The company’s CDA technology has shown to be advantageous over traditional detection methods, allowing it to outperform in the early detection market. The company’s main goal for 2021 is to extend its major discoveries in the field of early cancer detection and also develop cancer treatment technologies.

“This technical symposium allowed people to better understand the most cutting-edge applications of biophysical technology in cancer prevention and treatment, and it also played an important role in promoting future research and development in cancer prevention and treatment,” Dr. Chris Yu, CEO and Chairman of AnPac Bio, said. “As a pioneer in the application of biophysics to cancer prevention and treatment, AnPac Bio continues to report new ideas and cutting-edge technology to the public, sharing the latest clinical study and trial results, and continuing to promote collaborations between industry, and academia.”

AnPac Bio has proven to be an early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. The company’s patent applications and IP began in the early 2010’s, and by 2014 it had already announced a cancer screening product with the capability of screening 16 types of cancer earlier than anyone else in the industry.

AnPac Bio’s CDA technology combines the assessment of existing biomarkers with the biophysical properties and cellular proteins that signal the lead up to serious health conditions (including cancer). The technology can also be used to pinpoint the most likely location for cancer or predict where the risk will be high in the future. Having invented and championed the idea and method of “multi-level, multi-parameter” cancer screening, AnPac Bio’s contributions are now recognized and accepted by leading United States medical institutions and life science companies.

For more information, visit the company’s website at www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://nnw.fm/ANPC

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

AnPac Bio-Medical Science Co. Ltd. (ANPC) Stock Research Links

ANPC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR Investors Face Deadline in Class Action Case

Updated Category News Views 96

Investor Deadline Looms for BETR Losses Ah, the tangled web of finance promises and posturing! Investors in Better Home & Finance Holding Company (NASDAQ: BETR) are now standing at a financial crossroads, thanks to an unfolding legal drama. You've got until November 20, 2026, to align your ducks and join a federal securities class action lawsuit, put forth by Hagens...

Continue Reading
Blue Friday Sales: A Princess Cruises' Steal

Updated Category News Views 194

Setting Sail on Savings: Princess Cruises' Offerings When folks start talking about Black Friday, you probably think of TVs or gadgets, but Princess Cruises is flipping that idea with their 'Blue Friday' sale, running from November 6 through December 7, 2026. Now, cruises aren't your traditional doorbuster, but a vacation might just be the kind of experience worth...

Continue Reading
Maritime Injury Law: Neidzwski Talks Sea Changes

Updated Category News Views 96

Legal waters are as choppy as the seas themselves, especially in the maritime injury law arena. Nicholas J. Neidzwski, a maritime injury attorney and partner at BoatLaw, LLP, recently waded into these turbulent waters at the 2026 Pacific Admiralty Seminar. This isn’t just any gathering; it’s the West Coast’s legal beacon on all things maritime, drawing in industry...

Continue Reading
Capitol Securities Adds Financial Veterans to Team

Updated Category News Views 153

Big Moves in Sarasota: Capitol Securities' New Additions In a world where every Wall Street whisper can send ripples through financial markets, Capitol Securities Management's move to bring on Joe Malave and Katy Carrigan is anything but a minor footnote. You'd think, by now, we'd be numb to industry shifts, but when a pro like Malave, with his 30 years of financial...

Continue Reading
Pre-Owned Jet Inventory Rises; Price Trends Unclear

Updated Category News Views 137

October's Pre-Owned Aircraft Inventory: A Mixed Bag Nothing like leafing through October's data on pre-owned jets and feeling your stomach do that weird flip-flop. Inventory's nudging up, but it's still on its knees compared to last year's numbers. According to Sandhills Global's fresh aviation market reports, we got an increase in what's available on platforms like...

Continue Reading
Zylox-Tonbridge's Bold Move with LifeTech Investment

Updated Category News Views 132

An Investment That's Turning Heads Alright, here's a curveball for ya. Zylox-Tonbridge and GL Capital are throwing down a cool HK$1.482 billion into LifeTech Scientific, aiming for a high-stakes play in the vascular and structural heart field. This isn't just peanuts or pocket change; it's a concerted push to carve out a new landscape in China with something akin to a...

Continue Reading
Frederick's VFW Post Thrives with New Facility Launch

Updated Category News Views 118

The Power of Building a Legacy There I was, watching the home the VFW built not just with nails and beams, but conviction. In a world where construction and legacy often don't speak the same language, the Frederick VFW Post 3285 is flipping the script. We're looking at a story about real, tangible impact—not in the P&Ls but in actual lives. Brick by Brick: A...

Continue Reading
Precision Biologics Unveils Promising Data on PB-223

Updated Category News Views 95

Precision's Big Reveal at SITC 2026 When it comes to the shifting tides of oncology advancements, Precision Biologics is making some serious waves. They're not leaning back; they're diving right in with their latest showcase at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, 2026. CEO Dr. Philip M. Arlen announced compelling preclinical data for their...

Continue Reading
Harborside Inn Rebuilding: A Boost for Block Island

Updated Category News Views 75

A Fire Sparks New Beginnings on Block Island When the Harborside Inn went up in flames in August 2023, it left a gaping hole in Block Island's hospitality scene. Now, rising from the ashes, this landmark hotel is set for a major comeback, thanks to a hefty $8.5 million financing deal with The Washington Trust Company. It's a rebirth that's about more than just bricks and...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Magna International's Upcoming Earnings Release

Updated Category News Views 134

Understanding Magna International's Earnings Expectations Magna International (NYSE: MGA) is gearing up for its quarterly earnings announcement soon, which is set to captivate investors' attention. As the date approaches, it's essential for stakeholders to familiarize themselves with the latest expectations and historical performance, leading to informed investment...

Continue Reading
Scenic Valley Ranch Vineyards Achieves National Wine Accolades

Updated Category News Views 211

Scenic Valley Ranch Vineyards Earns Prestigious Wine Awards Scenic Valley Ranch Vineyards (SVR) is making a name for itself on a national level, recently receiving esteemed awards at two renowned wine competitions. The recognition came from the San Francisco Chronicle Wine Competition and the International Wine Competition, both respected for celebrating excellence within...

Continue Reading
OKX Europe Expands Institutional Services with MiFID II License

Updated Category News Views 150

OKX Europe Strengthens Institutional Services with License OKX, a renowned global blockchain technology company, has recently announced an exciting enhancement to its institutional offerings by acquiring a Markets in Financial Instruments Directive (MiFID II) licensed entity. This strategic move comes during an exclusive event held at Manoel Island, showcasing OKX's...

Continue Reading
Transform Your Investment: The Morgan Stanley Success Story

Updated Category News Views 391

Transform Your Investment: The Morgan Stanley Success Story Morgan Stanley (NASDAQ: MS) has shown remarkable resilience and growth in the stock market over the last five years. With an impressive annualized return of 20.25%, investors have seen significant gains that reflect the strength of their investment choices. Understanding Investment Growth To illustrate the impact...

Continue Reading
Discovering Field & Stream Lodge Co.'s Latest Adventure Hub

Updated Category News Views 245

Field & Stream Lodge Co. Launches Exciting New Location This new venture from Starwood Capital Group and AJ Capital Partners aims to provide affordable lifestyle lodging for outdoor enthusiasts. Field & Stream Lodge Co., born from the legacy of the iconic Field & Stream brand, has proudly announced its first location in Bozeman. Designed to inspire guests to embrace the...

Continue Reading